Diversifying manufacturing and investing into emerging technologies improves cost effectiveness, reproducibility, and environmentally friendly processes. Watch the video.

While AI is undoubtedly driving key progress in biotech, Travis McCready sees disruptive opportunity elsewhere. Discover why the Head of Life Sciences for Americas Markets at JLL is excited for regenerative medicine and tissue engineering in this interview. Watch the video.

Mary Claire Duch of Real Chemistry and Kathleen Tregoning from Cerevel Therapeutics talk all things AI in biotech, as well as the importance of countering misinformation through accurate and well-targeted communications. Watch the video.

Dr. Sharon Benzeno, Chief Commercial Officer of Immune Medicine at Adaptive Biotechnologies, shines a spotlight on the key immune-driven medicine advancements that show immense promise in transforming diagnoses, treatments, and patient outcomes. Watch the video.

Alexandra Canale, Managing Director of uncapped communications, discusses emerging technologies, scientific advancements and key opportunities in biotech. Watch the video.

What are the major challenges Life Sciences companies face in new product development? Cameron Izadi, Senior Vice President of Fingerpaint Market Access, joins Rebecca Williamson to assess the current landscape. Watch the video.

Emerging technologies and scientific advancements, specifically, artificial intelligence, robotics, and automation will impact industry in the industry in the next decade. Watch the video.